Announcement on Voluntary Disclosure of the Receipt of Marketing Approval for the New Drug Zihua Wenfei Zhisou Granules
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688658)"Youcare Pharmaceutical Group Co., Ltd."Announcement on Voluntary Disclosure of the Receipt of Marketing Approval for the New Drug Zihua Wenfei Zhisou Granules
Filed with SSE · Stock code 688658 · · 2 pages · Chinese
Summary by 6ix AI
Youcare Pharmaceutical Group Co. Ltd. has announced the receipt of marketing approval for its new drug Zihua Wenfei Zhisou Granules.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Youcare Pharmaceutical Group Co. Ltd. on 6ix
Story so far
- Announcement on Voluntary Disclosure of the Subsidiary's YKYY036 Injection Obtaining Clinical Trial Approvals from the National Medical Products Administration and the U.S. Food and Drug Administration
- Announcement on Opening a Raised Funds Account and Signing a Supervision Agreement for Deposit of Raised Funds in Special Account
- Announcement on the Use of a Portion of Over-raised Funds for Investment in New Projects
Earlier from Youcare Pharmaceutical
- Announcement on Voluntary Disclosure of the Subsidiary's YKYY036 Injection Obtaining Clinical Trial Approvals from the National Medical Products Administration and the U.S. Food and Drug Administration
- Announcement on Opening a Raised Funds Account and Signing a Supervision Agreement for Deposit of Raised Funds in Special Account
- Announcement on the Use of a Portion of Over-raised Funds for Investment in New Projects
- Announcement on Voluntary Disclosure of the Subsidiary's Receipt of FDA Clinical Trial Approval for YKYY033 Injection
- Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval from NMPA for New Indication of YKYY017 Inhalation Aerosol
Follow Youcare Pharmaceutical into a list and get an email when it puts out news.
Follow Youcare Pharmaceutical